Phase II trial of paclitaxel, ifosfamide, and carboplatin in extensive-stage small cell lung cancer-Reference-Cited by-同舟云学术

Phase II trial of paclitaxel, ifosfamide, and carboplatin in extensive-stage small cell lung cancer

Published:2003-04 Issue:1 Volume:40 Page:91-97
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Socinski Mark A.,Neubauer Marcus A.,Olivares Jairo,Ketchel Steven,Tynan Maureen,Moore Martha,Lee Ji-Hyun,Davis Kim,Schell Michael,Garfield David

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference29 articles.

1. Extensive stage small cell lung cancer;Gillenwater,2001

2. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small cell-lung cancer;Noda;N. Engl. J. Med.,2002

3. Randomized phase III intergroup trial (CALGB 9732) of etoposide (VP-16) and cisplatin (DDP) with or without paclitaxel (TAX) and G-CSF inpatients with extensive stage small cell lung cancer (ED-SCLC);Niell;Proc. Am. Soc. Clin. Oncol.,2002

4. A multicenter randomized clinical trial comparing paclitaxel–cisplatin–etoposide versus cisplatin–etoposide as first-line treatment in patients with small-cell lung cancer;Mavroudis;Ann. Oncol.,2001

5. Topotecan versus observation after cisplatin plus etoposide in extensive-stage small cell lung cancer: E7593-a phase III trial of the Eastern Cooperative Oncology Group;Schiller;J. Clini. Oncol.,2001

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Promising effects of 3rd line cyclophosphamide, adriamycin and vincristine (CAV) and 4th line ifosfamide and carboplatin chemotherapy in refractory small cell lung cancer;Thoracic Cancer;2015-01-27

2. Extensive Disease Small Cell Lung Cancer Dose-Response Relationships: Implications for Resistance Mechanisms;Journal of Thoracic Oncology;2010-11

3. Combination chemotherapy with paclitaxel and ifosfamide as the third-line regimen in patients with heavily pretreated small cell lung cancer;Lung Cancer;2007-10

4. Phase II Trial with Carboplatin and Bendamustine in Patients with Extensive Stage Small-Cell Lung Cancer;Journal of Thoracic Oncology;2007-04

5. Quality of Life in Lung Cancer: The Validity and Cross-Cultural Applicability of the Functional Assessment of Cancer Therapy–Lung Scale;Hematology/Oncology Clinics of North America;2005-04